Showing results (2471-2480 of 3,164) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|January 31, 2006
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay AreaMargaret Wrensch, Terri Rice, Rei Miike, et al.Neuro-Oncology|January 31, 2006
Temporal trends in incidence of primary brain tumors in the United States, 1985-1999Sara Hoffman, Jennifer M Propp, Bridget J McCarthyNeuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.Neuro-Oncology|May 15, 2008
Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant gliomaSurasak Phuphanich, Kathryn A Carson, Stuart A Grossman, et al.Neuro-Oncology|April 11, 2008
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncologyAlba A Brandes, Alicia Tosoni, Federica Spagnolli, et al.Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.Neuro-Oncology|March 25, 2008
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant gliomaDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.Neuro-Oncology|April 10, 2025
Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?Mariëtte E G Kranendonk, Raoull Hoogendijk, Julie A S Lammers, et al.Neuro-Oncology|April 10, 2025
S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicityYang Wang, Zhengxin Chen, Rui Li, et al.Pageof 317